ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cooper Companies acquire EndoSee

Share On Facebook
share on Linkedin
Print

Worth $44m

© Mike Hodges

The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women’s healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system.

The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.

Commenting on the transaction, Robert S. Weiss, Cooper’s president and chief executive officer, said, “The acquisition of EndoSee fits perfectly with CooperSurgical’s office/surgical strategy of bringing high quality products to the OB/GYN while leveraging our infrastructure. This product has been cleared by the FDA and we plan to launch the product in the U.S. in the middle of fiscal 2015.”

The Cooper Companies is a global medical device company that operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 9,000 employees with products sold in over 100 countries.

EndoSee Corporation, headquartered in Los Altos, California, is a privately held company that specializes in the development of a disposable office-based hysteroscopy system. The EndoSee Office Hysteroscope is a handheld, battery-operated, readily portable system that requires minimal setup and is easy to use. The system consists of a HandTower – incorporating a rechargeable battery, video and control electronics, and touch screen LCD display – and a sterile, disposable hysteroscopic cannula with a camera and light source at the tip and which enables distention of the uterine cavity for optimal visualization.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Comments are closed

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com